Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

Widespread resistance among circulating influenza A strains to at least one of the anti-influenza drugs is a major public health concern. A triple combination antiviral drug (TCAD) regimen comprised of amantadine, oseltamivir, and ribavirin has been shown to have synergistic and broad spectrum activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoopes, Justin D., Driebe, Elizabeth M., Kelley, Erin, Engelthaler, David M., Keim, Paul S., Perelson, Alan S., Rong, Libin, Went, Gregory T., Nguyen, Jack T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248427/
https://www.ncbi.nlm.nih.gov/pubmed/22220216
http://dx.doi.org/10.1371/journal.pone.0029778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248427/
https://www.ncbi.nlm.nih.gov/pubmed/22220216
http://dx.doi.org/10.1371/journal.pone.0029778

Ejemplares similares